NASDAQ · CLBT
Technology · Software - Infrastructure
$11.23
Down-$0.15 (-1.28%)
Updated Oct 7, 2026, 11:20 PM
SID Score
4.0/10
Composite research score
Smart Money
58/100
Neutral
Price performance · CLBT
1M range · 22 trading sessions · Daily adjusted prices
Prices through Oct 7, 2026
CLBT closed at $11.23 after 22 trading sessions, down 1.97% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 7, 2026 | $11.30 | $11.405 | $11.09 | $11.225 | 1.85M |
| Oct 6, 2026 | $11.315 | $11.44 | $11.21 | $11.37 | 1.39M |
| Oct 5, 2026 | $11.10 | $11.336 | $10.97 | $11.20 | 3.11M |
| Oct 2, 2026 | $11.14 | $11.216 | $10.965 | $11.07 | 2.05M |
| Oct 1, 2026 | $11.34 | $11.3945 | $11.03 | $11.14 | 1.84M |
| Sep 30, 2026 | $10.92 | $11.315 | $10.82 | $11.26 | 3.11M |
| Sep 29, 2026 | $11.00 | $11.01 | $10.80 | $10.93 | 3.51M |
| Sep 28, 2026 | $10.67 | $11.10 | $10.48 | $11.07 | 2.88M |
| Sep 25, 2026 | $11.34 | $11.34 | $10.70 | $10.79 | 3.43M |
| Sep 24, 2026 | $11.43 | $11.54 | $11.29 | $11.37 | 1.25M |
| Sep 23, 2026 | $11.71 | $11.88 | $11.47 | $11.50 | 3.44M |
| Sep 22, 2026 | $11.75 | $11.78 | $11.41 | $11.66 | 3.62M |
| Sep 21, 2026 | $11.62 | $11.655 | $11.32 | $11.56 | 4.42M |
| Sep 18, 2026 | $11.82 | $11.82 | $11.495 | $11.62 | 1.61M |
| Sep 17, 2026 | $11.43 | $11.83 | $11.34 | $11.82 | 1.84M |
| Sep 16, 2026 | $11.12 | $11.565 | $11.12 | $11.43 | 2.47M |
| Sep 15, 2026 | $11.41 | $11.56 | $11.23 | $11.25 | 4.55M |
| Sep 14, 2026 | $11.27 | $11.85 | $11.25 | $11.67 | 3.54M |
| Sep 11, 2026 | $11.42 | $11.50 | $11.05 | $11.23 | 2.37M |
| Sep 10, 2026 | $11.25 | $11.46 | $11.065 | $11.325 | 2.4M |
| Sep 9, 2026 | $11.42 | $11.555 | $11.25 | $11.43 | 2.63M |
| Sep 8, 2026 | $11.33 | $11.53 | $11.15 | $11.45 | 3.78M |
The latest Smart Investors Daily articles mentioning CLBT.
Company
Market Activity
Research & News
CLBT research
Company profile and research snapshot.
Cellebrite DI Ltd is an Israeli digital intelligence company that provides tools for federal, state, and local law enforcement as well as enterprise companies and service providers to collect, review, analyze, and manage digital data. Some of its products include Cellebrite UFED, Cellebrite Physical Analyzer, Cellebrite UFED Cloud, Cellebrite Frontliner, Cellebrite Responder, Cellebrite Premium, and Cellebrite Seeker.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Sep 15, 2026 | DA Davidson | Buy | — |
| Aug 14, 2026 | Lake Street | Buy | — |
| Aug 14, 2026 | JP Morgan | Overweight | — |
| Aug 14, 2026 | DA Davidson | Buy | — |
| Aug 14, 2026 | Needham | Buy | — |
No generated briefing is available yet.
Yahoo · Sep 29, 2026
This under-the-radar cybersecurity stock boasts a Superscore of 79 from our Hidden Gems Primary database, part of The Motley Fool's Moneyball Database system. Here's why.
Yahoo · Sep 23, 2026
Cellebrite (Nasdaq: CLBT), a global leader in Digital Investigative and Intelligence solutions for the public and private sectors, today announced the next evolution of the Digital Justice Awards, known as the JUSTYS. The 2027 program introduces more rigorous judging criteria, an elevated panel of judges and new crime-specific categories for its Case of the Year awards. The JUSTYS will be presented on Tuesday, April 13, 2027, during Cellebrite's annual C2C User Summit which attracts the best and
Yahoo · Sep 23, 2026
Twilio (TWLO) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Yahoo · Sep 22, 2026
Cellebrite DI (CLBT) sits in focus after recent share performance left the stock down over the past year, despite revenue of US$514.289m and net income of US$58.246m from its digital investigations platform. Cellebrite DI’s share price has slipped over recent months, with the stock down 35.2% year to date and 9.26% over the past quarter, even though the 30 day share price return of 4.62% shows a short burst of positive momentum against a weaker near term trend. Scan beyond Cellebrite DI and...
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning CLBT.
